scholarly article | Q13442814 |
P50 | author | Ronald A. DePinho | Q7364619 |
P2093 | author name string | Hao Li | |
Eric N Olson | |||
Jianping Liang | |||
Zhi-Ping Liu | |||
Diego H Castrillon | |||
P2860 | cites work | Synergistic upregulation of metalloproteinase-9 by growth factors and inflammatory cytokines: an absolute requirement for transcription factor NF-kappa B | Q64381924 |
Direct evidence for cytokine involvement in neointimal hyperplasia | Q73030700 | ||
Remodeling with neointima formation in the mouse carotid artery after cessation of blood flow | Q73832982 | ||
Isolation of vascular smooth muscle cells from a single murine aorta | Q78675064 | ||
Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase | Q24310456 | ||
Phenotypic modulation of smooth muscle cells through interaction of Foxo4 and myocardin | Q24311484 | ||
A conserved MST-FOXO signaling pathway mediates oxidative-stress responses and extends life span | Q24338599 | ||
FoxOs are lineage-restricted redundant tumor suppressors and regulate endothelial cell homeostasis | Q28285131 | ||
Disruption of forkhead transcription factor (FOXO) family members in mice reveals their functional diversification | Q28512492 | ||
Molecular regulation of vascular smooth muscle cell differentiation in development and disease | Q29615194 | ||
JNK regulates lifespan in Caenorhabditis elegans by modulating nuclear translocation of forkhead transcription factor/DAF-16. | Q33934548 | ||
Direct evidence for tumor necrosis factor-induced mitochondrial reactive oxygen intermediates and their involvement in cytotoxicity | Q33948462 | ||
Disialoganglioside (GD3) synthase gene expression suppresses vascular smooth muscle cell responses via the inhibition of ERK1/2 phosphorylation, cell cycle progression, and matrix metalloproteinase-9 expression | Q34324319 | ||
Matrix metalloproteinases: they're not just for matrix anymore! | Q34360566 | ||
JNK extends life span and limits growth by antagonizing cellular and organism-wide responses to insulin signaling | Q34410199 | ||
Mammalian smooth muscle differentiation: origins, markers and transcriptional control | Q34753392 | ||
Vascular smooth muscle diversity: insights from developmental biology | Q35095423 | ||
The ins and outs of FoxO shuttling: mechanisms of FoxO translocation and transcriptional regulation | Q35684376 | ||
FoxOs at the crossroads of cellular metabolism, differentiation, and transformation | Q35770614 | ||
Regulation of MMP-9 gene expression for the development of novel molecular targets against cancer and inflammatory diseases | Q35911136 | ||
Dual role of matrix metalloproteinases (matrixins) in intimal thickening and atherosclerotic plaque rupture | Q35993294 | ||
Triple layer control: phosphorylation, acetylation and ubiquitination of FOXO proteins. | Q36140005 | ||
A forkhead in the road to longevity: the molecular basis of lifespan becomes clearer | Q36155225 | ||
TNFalpha suppresses human colonic circular smooth muscle cell contractility by SP1- and NF-kappaB-mediated induction of ICAM-1. | Q38335467 | ||
Mechanism of rapid transcriptional induction of tumor necrosis factor alpha-responsive genes by NF-kappaB. | Q39681517 | ||
JNK antagonizes Akt-mediated survival signals by phosphorylating 14-3-3. | Q40398942 | ||
FOXO transcription factor activation by oxidative stress mediated by the small GTPase Ral and JNK. | Q40493379 | ||
NF-kappaB is required for TNF-alpha-directed smooth muscle cell migration | Q43812239 | ||
Matrix Metalloproteinase-2 and −9 Differentially Regulate Smooth Muscle Cell Migration and Cell-Mediated Collagen Organization | Q44612994 | ||
Loss of matrix metalloproteinase-9 or matrix metalloproteinase-12 protects apolipoprotein E-deficient mice against atherosclerotic media destruction but differentially affects plaque growth | Q45873353 | ||
Critical role of Mst1 in vascular remodeling after injury. | Q46551613 | ||
Molecular mechanism of transcriptional activation of human gelatinase B by proximal promoter | Q48060217 | ||
Forkhead transcription factors inhibit vascular smooth muscle cell proliferation and neointimal hyperplasia. | Q53670501 | ||
P4510 | describes a project that uses | ImageJ | Q1659584 |
P433 | issue | 7 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | cell migration | Q189092 |
P304 | page(s) | 2676-2686 | |
P577 | publication date | 2007-01-22 | |
P1433 | published in | Molecular and Cellular Biology | Q3319478 |
P1476 | title | FoxO4 regulates tumor necrosis factor alpha-directed smooth muscle cell migration by activating matrix metalloproteinase 9 gene transcription | |
P478 | volume | 27 |
Q37390262 | A fork in the path: Developing therapeutic inroads with FoxO proteins |
Q33603782 | A gene network switch enhances the oxidative capacity of ovine skeletal muscle during late fetal development |
Q91387630 | A network-based approach to uncover microRNA-mediated disease comorbidities and potential pathobiological implications |
Q92723448 | A novel CD147 inhibitor, SP-8356, reduces neointimal hyperplasia and arterial stiffness in a rat model of partial carotid artery ligation |
Q42058353 | Adiponectin induces vascular smooth muscle cell differentiation via repression of mammalian target of rapamycin complex 1 and FoxO4. |
Q34014519 | Autophagy in alcohol-induced multiorgan injury: mechanisms and potential therapeutic targets |
Q92833453 | Beetroot juice alleviates isoproterenol-induced myocardial damage by reducing oxidative stress, inflammation, and apoptosis in rats |
Q90035668 | Brain vascular intima vulnerability among HIV-positive and negative individuals |
Q39929531 | Codependent activators direct myoblast-specific MyoD transcription |
Q90140626 | Current perspective on the regulation of FOXO4 and its role in disease progression |
Q42080244 | ECM-related gene expression profile in vascular smooth muscle cells from human saphenous vein and internal thoracic artery |
Q84627462 | Erythropoietin, forkhead proteins, and oxidative injury: biomarkers and biology |
Q61815772 | Evaluation of neuroprotective effects of insulin on immuno-inflammatory and systemic disorders induced by kaliotoxin, a Kv1.3 channel blocker |
Q50147080 | Extracellular matrix molecules and their potential contribution to the function of transplanted pancreatic islets. |
Q33594004 | FOXO transcription factors: their clinical significance and regulation. |
Q37334058 | FOXO3a promotes tumor cell invasion through the induction of matrix metalloproteinases. |
Q28505995 | Forkhead box transcription factor FoxC1 preserves corneal transparency by regulating vascular growth |
Q37049891 | Forkhead transcription factors and cardiovascular biology |
Q36476460 | FoxC1-dependent regulation of vascular endothelial growth factor signaling in corneal avascularity |
Q37195595 | FoxO proteins: cunning concepts and considerations for the cardiovascular system |
Q51771664 | FoxO1 represses LXRα-mediated transcriptional activity of SREBP-1c promoter in HepG2 cells. |
Q35581071 | FoxO4 inhibits atherosclerosis through its function in bone marrow derived cells |
Q43091435 | FoxO4 promotes early inflammatory response upon myocardial infarction via endothelial Arg1. |
Q37235287 | Foxo3-/- mice demonstrate reduced numbers of pre-B and recirculating B cells but normal splenic B cell sub-population distribution |
Q24568374 | Gelatinase B/MMP-9 in Tumour Pathogenesis and Progression |
Q30009401 | Genomics of post-prandial lipidomic phenotypes in the Genetics of Lipid lowering Drugs and Diet Network (GOLDN) study |
Q57811107 | Hesperidin Prevents Nitric Oxide Deficiency-Induced Cardiovascular Remodeling in Rats via Suppressing TGF-β1 and MMPs Protein Expression |
Q64057065 | Inhibition of Brd4 alleviates renal ischemia/reperfusion injury-induced apoptosis and endoplasmic reticulum stress by blocking FoxO4-mediated oxidative stress |
Q35558873 | Isotretinoin and FoxO1: A scientific hypothesis |
Q37606038 | Lipoproteins, platelets and atherothrombosis |
Q58705256 | Long Noncoding RNA XR007793 Regulates Proliferation and Migration of Vascular Smooth Muscle Cell via Suppressing miR-23b |
Q55451622 | Loss of HtrA1 serine protease induces synthetic modulation of aortic vascular smooth muscle cells. |
Q91259885 | Matrix metalloproteinases in pro-atherosclerotic arterial remodeling |
Q36960275 | Matrix metalloproteinases: inflammatory regulators of cell behaviors in vascular formation and remodeling |
Q46474111 | Mechanism of matrix metalloproteinase axis-induced neointimal growth |
Q37504774 | MiR-150 promotes cellular metastasis in non-small cell lung cancer by targeting FOXO4. |
Q39124068 | NOX4 mediates activation of FoxO3a and matrix metalloproteinase-2 expression by urotensin-II |
Q47660630 | Opposing Actions of AKT (Protein Kinase B) Isoforms in Vascular Smooth Muscle Injury and Therapeutic Response |
Q33682262 | Oxidative stress: Biomarkers and novel therapeutic pathways |
Q81654439 | Poly(ADP-ribose) polymerase mediates inflammation in a mouse model of contact hypersensitivity |
Q34606581 | Regulation of arterial remodeling and angiogenesis by urokinase-type plasminogen activator. |
Q36965341 | Sequence variation at the human FOXO3 locus: a study of premature ovarian failure and primary amenorrhea |
Q92764264 | Smooth muscle-specific LKB1 deletion exaggerates angiotensin II-induced abdominal aortic aneurysm in mice |
Q30436555 | Sp1-dependent activation of KLF4 is required for PDGF-BB-induced phenotypic modulation of smooth muscle |
Q33824809 | The "O" class: crafting clinical care with FoxO transcription factors |
Q37776729 | The Extending Network of FOXO Transcriptional Target Genes |
Q37213756 | The transcription factor Foxf1 binds to serum response factor and myocardin to regulate gene transcription in visceral smooth muscle cells |
Q34467070 | Transcription factor Foxo1 is a negative regulator of natural killer cell maturation and function |
Q34540713 | Tumor necrosis factor-α regulates p27kip expression and apoptosis in smooth muscle cells of human carotid plaques via forkhead transcription factor O1 |
Q38963079 | Uncoupling angiogenesis and inflammation in peripheral artery disease with therapeutic peptide-loaded microgels |
Q35610737 | ZBRK1 acts as a metastatic suppressor by directly regulating MMP9 in cervical cancer |
Q41471224 | αMSH inhibits adipose inflammation via reducing FoxOs transcription and blocking Akt/JNK pathway in mice. |
Search more.